Answering Your Questions and Dispelling Myths About GLP-1 agonists Beyond BMI: The Truth About Obesity and GLP-1 Medications with Dr
If the medication works, exercise does not matter as much. I would argue the opposite
Research suggests that GLP-1s may affect immune cells and lower levels of inflammatory cytokines, such as TNF and IL-6, which are also involved in RA
However, compounded drugs are not FDA approved, which means FDA does not review them for safety, effectiveness or quality before they are marketed
Herein, we explore the longitudinal effect of the incretin effect on cell function in a contemporary cohort of adolescents with obesity and prediabetes evaluated during pubertal transition and 2 years later
2 , 8691 (2013) Hollenstein, K